Evommune Alternatives & Competitors
12 companies similar to Evommune — Developing innovative therapies that target key drivers of chronic inflammatory...
Companies similar to Evommune
FimmCyte
First disease modifying treatment for Endometriosis.
Basel, Switzerland
-Ltd.-logo. "CV6 Therapeutics, (NI) Ltd."){kind=logo}
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
United Kingdom
Ultragenyx
Going Beyond Every Day
Novato, United States
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Rival Readout
Competing with Evommune? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ACELYRIN, INC.
We are a late-stage clinical biopharma company focused on providing life-changing new trea...
Agoura Hills, United Stat...
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
Yaqrit
The Liver Disease Company
London, United Kingdom
Walden Biosciences
Transforming the Treatment of Kidney Disease
Cambridge, United States
Upstream Bio
Developing treatments for inflammatory diseases
Waltham, United States
CaSRevolution
A new hope for patients affected by Alzheimer’s disease
Milan, Italy
About Evommune
Evommune, founded in 2020, is a pioneering company in the fields of Biotechnology, Health Care, and Life Sciences, based in the United States. The company is making strides in addressing the pervasive challenge of chronic inflammation, which affects millions globally and is a precursor to numerous serious health condit...
Discovery and development of therapies for chronic inflammatory diseases, Pipeline advancement of product candidates, Hosting webinars and sharing scientific insights
Patients with chronic inflammatory diseases, Healthcare professionals
Chronic Inflammatory Diseases, Innovative Therapies, Tissue-Based Approach, Transformative Medicines, Disease Progression Prevention, Inflammatory Disorders, Best-in-Class Profiles, Patient Care, Research And Development, Symptom Management, Healthcare Innovation, Therapeutic Development, Pipeline Development
B2B, B2D
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Evommune: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Evommune on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
